Page last updated: 2024-08-26

carbobenzoxyproline and Melanoma

carbobenzoxyproline has been researched along with Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amidon, GL; Mittal, S; Song, X; Vig, BS	1

Other Studies

1 other study(ies) available for carbobenzoxyproline and Melanoma

Article	Year
Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma. Pharmaceutical research, 2007, Volume: 24, Issue:7 Topics: Antineoplastic Agents, Alkylating; Biological Transport; Biotransformation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chlorambucil; Dipeptidases; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydrolysis; Inhibitory Concentration 50; Melanoma; Melphalan; Prodrugs; Proline; Protease Inhibitors; RNA, Messenger; Stereoisomerism	2007

Article

Year

Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.

Pharmaceutical research, 2007, Volume: 24, Issue:7

Topics: Antineoplastic Agents, Alkylating; Biological Transport; Biotransformation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chlorambucil; Dipeptidases; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydrolysis; Inhibitory Concentration 50; Melanoma; Melphalan; Prodrugs; Proline; Protease Inhibitors; RNA, Messenger; Stereoisomerism

2007